One clinical trial of Opdivo involved adults with squamous non-small cell lung cancer (NSCLC). Researchers found that people with squamous NSCLC who took Opdivo had a lower risk of death compared ...

A pill has been shown to halve the risk of death from a certain type of lung ... size-fits-all treatment for people with non-small cell lung cancer." Osimertinib is already authorised in dozens ...

Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very ...

TTFields exert physical forces on the electrically charged components of dividing cancer cells, resulting in cell death. "The CE Mark approval for Optune Lua for metastatic non-small cell lung ...